Also, the fact that two benign tumors - oncocytoma and non-invasive papillary urothelial pTaG2 low grade carcinoma - showed occasional E-Cadherin loss suggests that reduced or absent E-Cadherin immunostaining is not invariably linked to tumor malignancy. This evidence concerns the gene CDH1 and benign neoplasm.